Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Liabilities

$46.42M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Total Liabilities

Latest reported$46.42Mperiod endingJun 30, 2026

Latest reported$46.42Mperiod endingJun 30, 2026

LCTX Quarterly Total Liabilities ($300.00K → $46.42M)

Quarterly total liabilities

High-resolution chart · PNG

LCTX total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Liabilities — Quarterly (USD)
Period ending	Total Liabilities (USD)
Jun 30, 2001	830,561
Mar 31, 2001	136,433
Dec 31, 2000	359,749
Sep 30, 2000	113,915
Jun 30, 2000	308,170
Mar 31, 2000	127,355
Dec 31, 1999	595,512
Sep 30, 1999	500,000
Jun 30, 1999	300,000
Mar 31, 1999	400,000
Sep 30, 1998	500,000
Jun 30, 1998	600,000
Mar 31, 1998	800,000
Dec 31, 1997	1,000,000
Sep 30, 1997	1,600,000
Jun 30, 1997	1,800,000
Mar 31, 1997	100,000
Dec 31, 1996	200,000
Sep 30, 1996	100,000
Jun 30, 1996	200,000
Sep 30, 1995	100,000
Jun 30, 1995	400,000
Mar 31, 1995	100,000
Dec 31, 1994	100,000
Sep 30, 1994	100,000
Jun 30, 1994	100,000
Mar 31, 1994	100,000
Dec 31, 1993	100,000
Sep 30, 1993	100,000
Jun 30, 1993	100,000
Mar 31, 1993	100,000
Dec 31, 1992	100,000
Sep 30, 1992	100,000
Jun 30, 1992	200,000
Mar 31, 1992	300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.